 LEXINGTON, Mass. , March 23, 2022 PRNewswire -- LogicBio Therapeutics, Inc. Nasdaq: LOGC, a clinical-stage genetic medicine company, today announced that president and chief executive officer, Frederic Chereau, will present a company overview at the H.C. 